Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 5/20 | 0.53 |
| ▸ | CA1 | P00915 | 4/20 | 0.53 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.46 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | CTSK | P43235 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | BIRC2 | Q13490 | 2/20 | 0.35 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.34 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | DPP4 | P27487 | 1/20 | 0.33 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.33 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL817645 | 0.93 | ZDHHC7 (0.56) | CA2CA1ZDHHC7ABCB1USP2 | |
| SCHEMBL817646 | 0.93 | ZDHHC7 (0.56) | CA2CA1ZDHHC7ABCB1USP2 | |
| SCHEMBL3626129 | 0.86 | CA2 (0.63) | CA2CA1ZDHHC7ABCB1TSHR | |
| SCHEMBL5692727 | 0.82 | CA2 (0.59) | CA2CA1ZDHHC7ABCB1TSHR | |
| SCHEMBL5731151 | 0.80 | CA2 (0.57) | CA2CA1ZDHHC7ABCB1TSHR | |
| SCHEMBL16534859 | 0.79 | SMN1; SMN2 (0.41) | CA2CA1ZDHHC7ALDH1A1 | |
| SCHEMBL2941499 | 0.79 | ZDHHC7 (0.62) | CA2CA1ZDHHC7ABCB1USP2 | |
| SCHEMBL6311489 | 0.78 | CA2 (0.55) | CA2CA1ZDHHC7ABCB1TSHR | |
| SCHEMBL11482438 | 0.78 | CA2 (0.55) | CA2CA1ZDHHC7ABCB1TSHR | |
| SCHEMBL16604554 | 0.78 | CA1 (0.55) | CA2CA1ZDHHC7ABCB1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110275838-A1 | METHOD FOR OBTAINING CINATRINS C3 AND C1 | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) | 2011-11-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110275838-A1 | METHOD FOR OBTAINING CINATRINS C3 AND C1 | C3AR1, CPA3, CYP21A2 | CA2 556/4885CA1 392/4885ZDHHC7 1313/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.